Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06210711 · ClinicalTrials.gov registry record · NA

Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center

A NA study of PTSD and Posttraumatic Stress Disorder, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
3
Study locations

NCT06210711 is a NA study of PTSD and Posttraumatic Stress Disorder that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 300 participants, roughly in line with the 300-participant average among 154 other PTSD trials with a reported enrollment target. The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06210711, a NA study of PTSD and Posttraumatic Stress Disorder, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Brief Prolonged Exposure Therapy

Study Locations (3)

Texas

  • Baylor University Medical Center - Dallas
  • Baylor Scott & White Medical Center - Temple - Temple

Wisconsin

  • Froedtert & Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-02-28
Est. Completion 2027-09
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT06210711

The ClinicalTrials.gov registry entry for NCT06210711 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 300-participant average among 154 other PTSD trials with a reported enrollment target. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT06210711 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06210711 about?

NCT06210711 is a clinical study titled "Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center". The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.

What is the current status of trial NCT06210711?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-02-28. Estimated completion is 2027-09.

What conditions does trial NCT06210711 study?

This clinical trial studies the following conditions: PTSD, Posttraumatic Stress Disorder, Traumatic Injury.

What interventions are being tested in trial NCT06210711?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Brief Prolonged Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06210711?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06210711 being conducted?

This trial has 3 study locations across Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.